Prognia
Drug Database
🇪🇺EU · EMARefusedATC: L01XE22Orphan Medicine

Alsitek(Masitinib mesilate)

Amyotrophic Lateral Sclerosis

Marketing Authorisation Holder: AB Science

INN: masitinib

Indication

Treatment of amyotrophic lateral sclerosis.

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Alsitek — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.